While we expect it can eventually get approval, the timeline is unclear. While Regeneron's Praluent has entered the multibillion-dollar cholesterol-lowering market, it faces stiff competition from ...

Under the terms of the agreement, FUJIFILM Diosynth Biotechnologies will provide US-based manufacturing for Regeneron over the 10-year period through current and planned expansions at its new ...